Skip to main content

Table 1 Patient characteristics

From: Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation

Case no. Age (y) Gender Prescribed dose (Gy(RBE)) Chemotherapy Risk-group
CSI Boost
1 7 F 23.4 30.6 CD SR
2 4 F 23.4 30.6 CD SR
3 5 M 23.4 30.6 HD SR
4 10 M 23.4 30.6 CD SR
5 4 M 23.4 30.6 HD SR
6 4 M 27.0 27.0 HD HR
7 6 M 30.6 19.8 HD HR
8 15 M 36.0 18.0 CD HR
9 9 M 36.0 18.0 CD HR
10 8 F 36.0 18.0 CD HR
11 5 F 36.0 18.0 CD HR
12 4 F 36.0 18.0 HD HR
  1. Abbreviations: M male, F female, HD high-dose chemotherapy, CD conventional-dose chemotherapy, SR standard-risk, and HR high-risk.